Home » Topics » BioWorld Science

BioWorld Science
RSS

Preclinical results for N-3389 in emesis

May 5, 1997

Dual D2/beta2 agonists disclosed by Astra

May 5, 1997

Agents specific for dopamine D3 receptors described by Neurogen

May 5, 1997

Delta-opioid receptor ligands reported by SmithKline Beecham

May 5, 1997

Biomatrix's viscosupplementation product to be distributed by Bayer

May 2, 1997

OXiGENE initiates U.S. preclinical and clinical research

May 2, 1997

Abbott to acquire certain Sanofi businesses

May 2, 1997

CoCensys and Novartis end stroke compound collaboration

May 2, 1997

Alpharma's Oral Acyclovir Suspension launched in the U.S.

May 2, 1997

Nanogen granted U.S. patent on APEX technology

May 2, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...